Colleen Fullenkamp

469 total citations
11 papers, 340 citations indexed

About

Colleen Fullenkamp is a scholar working on Molecular Biology, Rheumatology and Cell Biology. According to data from OpenAlex, Colleen Fullenkamp has authored 11 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Rheumatology and 3 papers in Cell Biology. Recurrent topics in Colleen Fullenkamp's work include Hippo pathway signaling and YAP/TAZ (3 papers), Bone Metabolism and Diseases (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Colleen Fullenkamp is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (3 papers), Bone Metabolism and Diseases (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Colleen Fullenkamp collaborates with scholars based in United States, Australia and Canada. Colleen Fullenkamp's co-authors include Janet A. Fairley, Kelly N. Messingham, Rupasree Srikantha, Munir R. Tanas, Richard E. Buller, Joel I. Sorosky, Barrie Anderson, Anil K. Sood, Jeffrey Gorski and Allyn M. Lambertz and has published in prestigious journals such as PLoS ONE, The FASEB Journal and European Journal of Immunology.

In The Last Decade

Colleen Fullenkamp

11 papers receiving 337 citations

Peers

Countries citing papers authored by Colleen Fullenkamp

Since Specialization

Citations

This map shows the geographic impact of Colleen Fullenkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Fullenkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Fullenkamp more than expected).

Fields of papers citing papers by Colleen Fullenkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Fullenkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Fullenkamp. The network helps show where Colleen Fullenkamp may publish in the future.

Co-authorship network of co-authors of Colleen Fullenkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Fullenkamp. A scholar is included among the top collaborators of Colleen Fullenkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Fullenkamp. Colleen Fullenkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex 2021 ·eLife ·(unknown), (unknown), Dushyandi Rajendran, Zhen‐Yuan Lin, Xiaomeng Zhang, (unknown), Nicholas Borcherding, Colleen Fullenkamp, Michael S. Chimenti, Anne‐Claude Gingras, Kieran F. Harvey, Munir R. Tanas	39
2	A comprehensive evaluation of Hippo pathway silencing in sarcomas 2018 ·Oncotarget ·(unknown), Colleen Fullenkamp, (unknown), (unknown), Chandni Desai, (unknown), Allyn M. Lambertz, Adam J. Dupuy, Benjamin W. Darbro, Munir R. Tanas	18
3	TAZ and YAP are frequently activated oncoproteins in sarcomas 2016 ·Oncotarget ·Colleen Fullenkamp, (unknown), Omar Jaber, (unknown), (unknown), (unknown), (unknown), Allyn M. Lambertz, (unknown), Christopher S. Stipp, Benjamin J. Miller, Mohammed Milhem, Munir R. Tanas	64
4	Human Eosinophils Express the High Affinity IgE Receptor, FcεRI, in Bullous Pemphigoid 2014 ·PLoS ONE ·Kelly N. Messingham, (unknown), (unknown), Colleen Fullenkamp, Rupasree Srikantha, Janet A. Fairley	71
5	Missing the target: Characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay 2012 ·Journal of the American Academy of Dermatology ·Janet A. Fairley, (unknown), Colleen Fullenkamp, Sergei Syrbu, Mei Chen, Kelly N. Messingham	35
6	Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK‐cell receptor Ly49H 2010 ·European Journal of Immunology ·Natalya V. Guseva, Colleen Fullenkamp, Paul Naumann, (unknown), Zuhair K. Ballas, Jon C. D. Houtman, Catherine A. Forbes, Anthony A. Scalzo, Jonathan W. Heusel	7
7	Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18 2003 ·Cancer Immunology Immunotherapy ·(unknown), Zoya Kurago, Colleen Fullenkamp, Charles T. Lutz	12
8	Bone acidic glycoprotein-75 self-associates to form macromolecular complexes in vitro and in vivo with the potential to sequester phosphate ions 1997 ·Journal of Cellular Biochemistry ·Jeffrey Gorski, (unknown), (unknown), (unknown), Colleen Fullenkamp, (unknown), Karen Jensen, Marc D. McKee	20
9	The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis. 1997 ·PubMed ·Richard E. Buller, Anil K. Sood, Colleen Fullenkamp, Joel I. Sorosky, (unknown), Barrie Anderson	49
10	Bone acidic glycoprotein‐75 self‐associates to form macromolecular complexes in vitro and in vivo with the potential to sequester phosphate ions 1997 ·Journal of Cellular Biochemistry ·Jeffrey Gorski, (unknown), (unknown), (unknown), Colleen Fullenkamp, (unknown), Karen Jensen, Marc D. McKee	2
11	Bone acidic glycoprotein 75 inhibits resorption activity of isolated rat and chicken osteoclasts 1992 ·The FASEB Journal ·Masahiko Sato, W A Grasser, (unknown), Colleen Fullenkamp, Jeffrey Gorski	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact